Finance

Lists
Why is LUNG down 4.67%?
Dive Deeper
LUNG:NASDAQ
Pulmonx Corp
US$2.86
-4.67%
(-0.14) 1D
ኖቬም 13, 4:00:01 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LUNG...
Open
US$2.99
High
US$3.04
Low
US$2.78
Mkt. cap
124.55 ሚ
Avg. vol.
956.48 ሺ
Volume
695.08 ሺ
52-wk high
US$3.25
52-wk low
US$1.13
EPS
-US$1.01
Beta
0.19
Shares outstanding
43.55 ሚ
No. of employees
296
Open
US$2.99
High
US$3.04
Low
US$2.78
Mkt. cap
124.55 ሚ
Avg. vol.
956.48 ሺ
Volume
695.08 ሺ
52-wk high
US$3.25
52-wk low
US$1.13
EPS
-US$1.01
Beta
0.19
Shares outstanding
43.55 ሚ
No. of employees
296
News stories
From web sources and news partners
About Pulmonx Corp
CEO-
Employees296
Founded1995
HeadquartersRedwood City, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryMedical device
Websitepulmonx.com
Analyst ratings
Based on 4 analysts giving stock ratings to LUNG in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for LUNG in the last 3 months.
Highest
Current US$2.86
US$5.00 (+74.83%)
Average
US$3.63 (+26.92%)
Lowest
US$2.50 (-12.59%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Young CFA
Canaccord Genuity
Buy
Reiterated
US$5.00
+74.8%
10/28/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
US$3.00
+4.9%
10/28/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
US$2.50
-12.6%
10/28/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
US$4.00
+39.9%
10/28/2026
Frank Takkinen
Lake Street
Buy
Reiterated
US$4.00
+39.9%
07/30/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
US$5.00
+74.8%
04/30/2026
Last report
27 ኦክቶ 2026
Fiscal period
Q3 2026
-US$0.19 / -US$0.26
+25.78%beat
Revenue / Est. (USD)
22.84 ሚ / 21.94 ሚ
+4.06%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
22.60 ሚ
20.59 ሚ
22.76 ሚ
22.84 ሚ
Cost of goods sold
5.06 ሚ
4.54 ሚ
5.01 ሚ
5.44 ሚ
Cost of revenue
5.06 ሚ
4.54 ሚ
5.01 ሚ
5.44 ሚ
Research and development expenses
4.58 ሚ
4.90 ሚ
5.03 ሚ
4.86 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.86 ሚ
24.10 ሚ
21.76 ሚ
20.02 ሚ
Operating expense
27.44 ሚ
29.00 ሚ
26.80 ሚ
24.89 ሚ
Total operating expenses
32.50 ሚ
33.54 ሚ
31.81 ሚ
30.32 ሚ
Operating income
-9.90 ሚ
-12.96 ሚ
-9.06 ሚ
-7.49 ሚ
Other non operating income
81.00 ሺ
277.00 ሺ
99.00 ሺ
-64.00 ሺ
EBT including unusual items
-10.24 ሚ
-13.50 ሚ
-9.95 ሚ
-8.24 ሚ
EBT excluding unusual items
-10.24 ሚ
-13.50 ሚ
-9.95 ሚ
-8.24 ሚ
Income tax expense
186.00 ሺ
149.00 ሺ
133.00 ሺ
151.00 ሺ
Effective tax rate
-1.82%
-1.10%
-1.34%
-1.83%
Other operating expenses
-
-
-
-
Net income
-10.42 ሚ
-13.65 ሚ
-10.08 ሚ
-8.39 ሚ
Net profit margin
-46.13%
-66.33%
-44.30%
-36.76%
Earnings per share
-0.25
-0.33
-0.24
-0.19
Interest and investment income
453.00 ሺ
350.00 ሺ
329.00 ሺ
345.00 ሺ
Interest expense
-770.00 ሺ
-976.00 ሺ
-1.22 ሚ
-1.23 ሚ
Net interest expenses
-317.00 ሺ
-626.00 ሺ
-889.00 ሺ
-889.00 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.57 ሚ
-12.84 ሚ
-8.84 ሚ
-7.18 ሚ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች